These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 16723578)

  • 1. Functional, biophysical, and structural bases for antibacterial activity of tigecycline.
    Olson MW; Ruzin A; Feyfant E; Rush TS; O'Connell J; Bradford PA
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2156-66. PubMed ID: 16723578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural characterization of an alternative mode of tigecycline binding to the bacterial ribosome.
    Schedlbauer A; Kaminishi T; Ochoa-Lizarralde B; Dhimole N; Zhou S; López-Alonso JP; Connell SR; Fucini P
    Antimicrob Agents Chemother; 2015 May; 59(5):2849-54. PubMed ID: 25753625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis for potent inhibitory activity of the antibiotic tigecycline during protein synthesis.
    Jenner L; Starosta AL; Terry DS; Mikolajka A; Filonava L; Yusupov M; Blanchard SC; Wilson DN; Yusupova G
    Proc Natl Acad Sci U S A; 2013 Mar; 110(10):3812-6. PubMed ID: 23431179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of tetracycline and tigecycline binding to ribosomes mapped by dimethylsulphate and drug-directed Fe2+ cleavage of 16S rRNA.
    Bauer G; Berens C; Projan SJ; Hillen W
    J Antimicrob Chemother; 2004 Apr; 53(4):592-9. PubMed ID: 14985271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tigecycline is modified by the flavin-dependent monooxygenase TetX.
    Moore IF; Hughes DW; Wright GD
    Biochemistry; 2005 Sep; 44(35):11829-35. PubMed ID: 16128584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Putative dioxygen-binding sites and recognition of tigecycline and minocycline in the tetracycline-degrading monooxygenase TetX.
    Volkers G; Damas JM; Palm GJ; Panjikar S; Soares CM; Hinrichs W
    Acta Crystallogr D Biol Crystallogr; 2013 Sep; 69(Pt 9):1758-67. PubMed ID: 23999299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tigecycline - how powerful is it in the fight against antibiotic-resistant bacteria?
    Seputiene V; Povilonis J; Armalyte J; Suziedelis K; Pavilonis A; Suziedeliene E
    Medicina (Kaunas); 2010; 46(4):240-8. PubMed ID: 20571291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negamycin induces translational stalling and miscoding by binding to the small subunit head domain of the Escherichia coli ribosome.
    Olivier NB; Altman RB; Noeske J; Basarab GS; Code E; Ferguson AD; Gao N; Huang J; Juette MF; Livchak S; Miller MD; Prince DB; Cate JH; Buurman ET; Blanchard SC
    Proc Natl Acad Sci U S A; 2014 Nov; 111(46):16274-9. PubMed ID: 25368144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of tigecycline--the first glycylcycline.
    Peterson LR
    Int J Antimicrob Agents; 2008 Dec; 32 Suppl 4():S215-22. PubMed ID: 19134522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of tigecycline tested against a global collection of Enterobacteriaceae, including tetracycline-resistant isolates.
    Fritsche TR; Strabala PA; Sader HS; Dowzicky MJ; Jones RN
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):209-13. PubMed ID: 16105566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tigecycline: a new glycylcycline for treatment of serious infections.
    Noskin GA
    Clin Infect Dis; 2005 Sep; 41 Suppl 5():S303-14. PubMed ID: 16080069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishing the role of tigecycline in an era of antimicrobial resistance.
    Schafer JJ; Goff DA
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):557-67. PubMed ID: 18847395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of in vitro activities of tigecycline, doxycycline, and tetracycline against the spirochete Borrelia burgdorferi.
    Ates L; Hanssen-Hübner C; Norris DE; Richter D; Kraiczy P; Hunfeld KP
    Ticks Tick Borne Dis; 2010 Mar; 1(1):30-4. PubMed ID: 21771509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induced tigecycline resistance in Streptococcus pneumoniae mutants reveals mutations in ribosomal proteins and rRNA.
    Lupien A; Gingras H; Leprohon P; Ouellette M
    J Antimicrob Chemother; 2015 Nov; 70(11):2973-80. PubMed ID: 26183184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presence of tetracycline resistance determinants and susceptibility to tigecycline and minocycline.
    Fluit AC; Florijn A; Verhoef J; Milatovic D
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1636-8. PubMed ID: 15793159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tigecycline: first of a new class of antimicrobial agents.
    Rose WE; Rybak MJ
    Pharmacotherapy; 2006 Aug; 26(8):1099-110. PubMed ID: 16863487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimalarial activity of tigecycline, a novel glycylcycline antibiotic.
    Starzengruber P; Thriemer K; Haque R; Khan WA; Fuehrer HP; Siedl A; Hofecker V; Ley B; Wernsdorfer WH; Noedl H
    Antimicrob Agents Chemother; 2009 Sep; 53(9):4040-2. PubMed ID: 19596882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The structural basis for the action of the antibiotics tetracycline, pactamycin, and hygromycin B on the 30S ribosomal subunit.
    Brodersen DE; Clemons WM; Carter AP; Morgan-Warren RJ; Wimberly BT; Ramakrishnan V
    Cell; 2000 Dec; 103(7):1143-54. PubMed ID: 11163189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tigecycline: a critical analysis.
    Stein GE; Craig WA
    Clin Infect Dis; 2006 Aug; 43(4):518-24. PubMed ID: 16838243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tigecycline: what is it, and where should it be used?
    Livermore DM
    J Antimicrob Chemother; 2005 Oct; 56(4):611-4. PubMed ID: 16120626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.